Australia Aims to be Global Leader of mRNA Development

Regarding corruption against its people, Australia and the United States have much in common. Immigrants take priority over citizens, children are heavily indoctrinated by a perverse woke agenda in school, and both current governments promote the enormously profitable, experimental cash cow that is mRNA “vaccines.” Never mind that when they forced the contaminated mRNA jabs on the masses during COVID-19, untold numbers of people were killed as a direct result. Presently, by investing millions of dollars in mRNA labs, a new government initiative in Australia aims to make the nation the world leader in the most destructive medical technology of our time, professing it seeks to cure diseases and prevent pandemics. Which country will actually take the lead? Only time will tell.

https://twitter.com/PaulineHansonOz/status/1828931853178548324

As we all know, the COVID-19 pandemic finally provided the decades-in-the-making mRNA injections an international platform for its much-anticipated debut. Individuals who fell prey to the doom and gloom propaganda—including those forced to take part or lose their livelihoods—became uninformed participants in what is undoubtedly the largest ongoing global clinical trial of an untested product with devastating gene-damaging capabilities in the history of civilization. With that in mind, instead of pausing to assess the damages, those swearing to safeguard our health are rapidly forging ahead with plans to expand mRNA technology at a record pace.

Under the leadership of Anthony Norman Albanese (a friend of Klaus Schwab), Australia’s Albanese Labor Government recently announced that millions of dollars are being invested in mRNA labs across the country. Referencing the “promise” shown by mRNA “vaccines” during COVID-19, Australia’s RNA Blueprint hopes to add up to $8 billion to the nation’s GDP over the next decade.

The blueprint was developed in response to the Government’s ‘Shaping our RNA Future’ consultation and builds on the earlier release of its Medical Science Co-investment Plan, which seeks to “capture more value from Australia’s world-leading medical science sector.” And, like the Democrat’s tyrannical “Build Back Better” agenda, it is conceived to enable Australia to navigate the unprecedented change occurring due to global megatrends such as climate change, digitalization, and geopolitical shifts.

According to Sky News, governments and some of the world’s largest pharmaceutical companies see Australia as the potential center of the mRNA universe. They report this is mainly due to easy-to-navigate regulations and a wealth of talent and experience in nanomedicine. Not to mention private company cash and taxpayer funds that are “pouring in,” including $94 million from the New South Wales government for a manufacturing facility and some of the $22 billion from the Future Made in Australia Fund. One of Australia’s strategic partnerships to rule mRNA is with none other than Moderna.

On March 23, 2022, Moderna—who quietly worked with the U.S. government’s Defense Advanced Research Projects Agency (DARPA) for decades on mRNA technology leading up to the COVID jab rollout—announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA “vaccine” manufacturing facility in Australia. The news finalized, in principle, an agreement with the Australian Federal Government that was announced in December 2021. With at least 28 products in its mRNA pipeline against everything from respiratory viruses, including COVID-19, to seasonal influenza, respiratory syncytial virus (RSV), other potential respiratory viruses, and threats to global public health, Moderna CEO Stéphane Bancel said of the partnership:

“We are delighted to reach this milestone with the Australian Government and finalize our first on-shore manufacturing agreement. The Australian Federal Government has been a great partner, and we are pleased to expand this partnership to support Australia’s mRNA life sciences ecosystem and global public health.”

Joining Moderna in empowering Australia to dominate mRNA, Australia’s experts have already created breakthroughs, including the University of Sydney team’s new gene-editing SeekRNA, which goes beyond CRISPR to provide “greater accuracy and flexibility than the industry standard” currently set by CRISPR. Monash University in Melbourne is also working on new ways to deliver mRNA, and Perth’s PYC Therapeutics is on track to create a “world-first treatment” to cure a form of blindness. And they’re not just working on human health; PYC is one step ahead of a potential foot and mouth disease outbreak in the country’s $75 billion red meat and livestock industry. Still, make no mistake, Australia also aims to dominate the cultivated meat market. An Australian start-up is now the fourth company approved globally to sell a cultivated meat product.

With Joe Biden’s United States, for now, and Australia in lockstep with the deep state agenda to usher in the UN Sustainability Goals, which country will dominate the lucrative mRNA market? And the bigger question: after the mRNA gene-damaging jab disaster that first pledged to prevent, then merely treat, then ultimately worsen, COVID-19, while causing devastating side effects, will there be a willing group of participants for a technology that undoubtedly merges humans with technology? Moreover, in the United States, with the childhood vaccine schedule out of control and a nation of unhealthy children, do they notice that we are on to them? Indeed, time will tell. Either way, the United States isn’t sitting idly in the mRNA race.

On July 2, 2024, Moderna announced it had received a $176 million project award from the U.S. Department of Health and Human Services (HHS)—specifically the Biomedical Advanced Research and Development Authority (BARDA)—to accelerate the development of “mRNA-based pandemic influenza vaccines” supporting the late-stage development for an mRNA “vaccine” to enable the licensure of a pre-pandemic “vaccine” against H5 influenza virus. The press release stated, “This subtype of influenza virus causes a highly infectious, severe disease in birds called avian influenza and poses a risk for spillover into the human population,” adding, “The agreement also includes additional options to prepare and accelerate a response to future public health threats.”

They keep telling us the next pandemic is coming. Indeed, as a critical election approaches with a potential outcome that threatens to shut down those aiming to rob humanity of its health and freedoms, fear is in the air. But, intent not to be a part of the next batch of mRNA guinea pigs, hope is alive for many more.